A real-world study of patients with Clostridioides difficile infection (CDI) in Australia over 10 years shows that fecal ...

Among the more concerning findings in the report is that data from more than half of European countries show high resistance ...

Opens in a new tab or window According to the company, the product is the first and only fixed-dose, intravenous, monobactam/beta-lactamase inhibitor combination antibiotic to receive FDA approval.

Chengdu Tetrahedral Drug Research Co. Ltd. has synthesized bicyclic derivatives acting as β-lactamase (bacterial) inhibitors reported to be useful for the treatment of bacterial infection.

More information: Abstract: In vitro activity of antimicrobial peptide from African catfish against the Extended-Spectrum ...

The following is a summary of “Discrepancies in Beta-Lactam Antibiotics Cross-Reactivity: Implications for Clinical Practice,” published in the February 2025 issue of European Journal of Allergy and ...

American researchers say it could one day represent a potent new tool against antimicrobial-resistant bacteria such as extended-spectrum beta-lactamase (ESBL) producing E. coli. Project leader Dr ...

that may inactivate certain beta-lactamase enzymes. Take with meals. Base dose on amoxicillin component. Due to clavulanic acid component: two 250mg tabs are not equivalent to one 500mg tab.

that may inactivate certain beta-lactamase enzymes. <3months: not recommended. Take with food. Base dose on amoxicillin component. Due to clavulanic acid component, ES-600 is not interchangable ...